These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24857366)

  • 1. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
    Pinkus JL; Amato AA; Taylor JP; Greenberg SA
    Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic interaction of hnRNPA2B1 and DNAJB6 in a Drosophila model of multisystem proteinopathy.
    Li S; Zhang P; Freibaum BD; Kim NC; Kolaitis RM; Molliex A; Kanagaraj AP; Yabe I; Tanino M; Tanaka S; Sasaki H; Ross ED; Taylor JP; Kim HJ
    Hum Mol Genet; 2016 Mar; 25(5):936-50. PubMed ID: 26744327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
    Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
    Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
    Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
    Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
    Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis.
    Fifita JA; Zhang KY; Galper J; Williams KL; McCann EP; Hogan AL; Saunders N; Bauer D; Tarr IS; Pamphlett R; Nicholson GA; Rowe D; Yang S; Blair IP
    Neurodegener Dis; 2017; 17(6):304-312. PubMed ID: 29131108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
    Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
    Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions.
    Tawara N; Yamashita S; Kawakami K; Kurashige T; Zhang Z; Tasaki M; Yamamoto Y; Nishikami T; Doki T; Zhang X; Matsuo Y; Kimura E; Tawara A; Maeda Y; Hauschka SD; Maruyama H; Ando Y
    Exp Neurol; 2018 Nov; 309():169-180. PubMed ID: 30130494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
    Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.
    Salajegheh M; Pinkus JL; Taylor JP; Amato AA; Nazareno R; Baloh RH; Greenberg SA
    Muscle Nerve; 2009 Jul; 40(1):19-31. PubMed ID: 19533646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.
    Cortese A; Plagnol V; Brady S; Simone R; Lashley T; Acevedo-Arozena A; de Silva R; Greensmith L; Holton J; Hanna MG; Fisher EM; Fratta P
    Neurobiol Aging; 2014 Jun; 35(6):1491-8. PubMed ID: 24462217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
    Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
    Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
    Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with "multisystem proteinopathy" and frontotemporal lobar degeneration phenotypes.
    Le Ber I; Van Bortel I; Nicolas G; Bouya-Ahmed K; Camuzat A; Wallon D; De Septenville A; Latouche M; Lattante S; Kabashi E; Jornea L; Hannequin D; Brice A;
    Neurobiol Aging; 2014 Apr; 35(4):934.e5-6. PubMed ID: 24119545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.
    Salajegheh M; Pinkus JL; Nazareno R; Amato AA; Parker KC; Greenberg SA
    Muscle Nerve; 2009 Oct; 40(4):520-8. PubMed ID: 19626672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.
    Yamashita S; Matsuo Y; Tawara N; Hara K; Yamamoto M; Nishikami T; Kawakami K; Zhang X; Zhang Z; Doki T; Ando Y
    Sci Rep; 2019 Aug; 9(1):11606. PubMed ID: 31406156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.
    Schmidt J; Barthel K; Wrede A; Salajegheh M; Bähr M; Dalakas MC
    Brain; 2008 May; 131(Pt 5):1228-40. PubMed ID: 18420712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
    Kim JH; Hahm B; Kim YK; Choi M; Jang SK
    J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.
    Beijer D; Kim HJ; Guo L; O'Donovan K; Mademan I; Deconinck T; Van Schil K; Fare CM; Drake LE; Ford AF; Kochański A; Kabzińska D; Dubuisson N; Van den Bergh P; Voermans NC; Lemmers RJ; van der Maarel SM; Bonner D; Sampson JB; Wheeler MT; Mehrabyan A; Palmer S; De Jonghe P; Shorter J; Taylor JP; Baets J
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.